|
|
Q3 2024
Filed on Nov 14, 2024
|
26,817
|
$30.32 - $41.21
$813K - $1.11M
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
15,800
|
$17.13 - $23.17
$271K - $366K
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
36,500
|
$13.7 - $17.0
$500K - $621K
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
31,300
|
$0.0 - $26.42
$0 - $827K
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
124,100
|
N/A
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
24,302
|
$3.8 - $4.65
$92.3K - $113K
|
|
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
19,200
|
$6.28 - $17.68
$121K - $339K
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
134,300
|
$11.7 - $16.51
$1.57M - $2.22M
|
|
Inovio Pharmaceuticals Inc
|
Q3 2024
Filed on Nov 14, 2024
|
21,756
|
N/A
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
18,569
|
$180.0 - $225.24
$3.34M - $4.18M
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
13,955
|
$1.96 - $4.08
$27.4K - $56.9K
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
107,315
|
$70.09 - $78.74
$7.52M - $8.45M
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
19,997
|
$2.01 - $3.31
$40.2K - $66.2K
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
24,735
|
N/A
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
18,312
|
$0.48 - $13.79
$8.79K - $253K
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
23,426
|
$20.48 - $33.15
$480K - $777K
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
169,348
|
$2.08 - $3.5
$352K - $593K
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
14,565
|
$0.7 - $0.82
$10.2K - $11.9K
|
|
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
140,000
|
$1.81 - $8.13
$253K - $1.14M
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
40,972
|
$0.25 - $11.23
$10.2K - $460K
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
20,200
|
$48.61 - $65.14
$982K - $1.32M
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
10,000
|
$32.37 - $38.91
$324K - $389K
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
70,000
|
$5.44 - $7.23
$381K - $506K
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
17,659
|
$1.07 - $1.75
$18.9K - $30.9K
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
18,563
|
$54.26 - $67.71
$1.01M - $1.26M
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
31,400
|
$7.44 - $12.86
$234K - $404K
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
14,903
|
$1.01 - $2.15
$15.1K - $32K
|
|
Allarity Therapeutics Inc
|
Q3 2024
Filed on Nov 14, 2024
|
38,795
|
N/A
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
11,463
|
$0.54 - $0.92
$6.19K - $10.5K
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
13,400
|
N/A
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
11,967
|
$116.28 - $141.69
$1.39M - $1.7M
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
98,597
|
$7.36 - $9.66
$726K - $952K
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
15,301
|
$5.37 - $7.28
$82.2K - $111K
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
13,500
|
$3.31 - $5.54
$44.7K - $74.8K
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
42,953
|
$4.49 - $7.2
$193K - $309K
|
|
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
13,923
|
$0.57 - $0.97
$7.94K - $13.5K
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
46,230
|
$70.41 - $88.25
$3.26M - $4.08M
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
7,286
|
$141.97 - $159.66
$1.03M - $1.16M
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
52,958
|
$0.29 - $0.51
$15.4K - $27K
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
22,524
|
$1.12 - $1.4
$25.2K - $31.5K
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
2,825
|
$92.85 - $119.61
$262K - $338K
|
|
Adverum Biotechnologies Inc
|
Q3 2024
Filed on Nov 14, 2024
|
24,203
|
N/A
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
17,733
|
N/A
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
267,361
|
$1.66 - $2.67
$444K - $714K
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
10,135
|
$11.64 - $17.35
$118K - $176K
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
4,197
|
$85.41 - $110.34
$358K - $463K
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
89,888
|
$20.78 - $28.78
$1.87M - $2.59M
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
17,371
|
$11.55 - $12.46
$201K - $216K
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
28,431
|
$0.48 - $1.02
$13.6K - $29K
|
|
|
|
Q3 2024
Filed on Nov 14, 2024
|
37,695
|
$8.24 - $11.48
$311K - $433K
|
|